Skip to content

F13.959

Billable

Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified

Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)

Is F13.959 an HCC code?

Yes. F13.959 maps to Drug/Alcohol Psychosis under the CMS-HCC V28 risk adjustment model (and Drug/Alcohol Psychosis under V24).

HCC Category Mapping

V28HCC 135Drug/Alcohol Psychosis
0.000
V24HCC 54Drug/Alcohol Psychosis
0.434
ESRDHCC 54Drug/Alcohol Psychosis
0.000

RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.

MEAT Criteria for F13.959

For F13.959 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.

  • MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
  • EEvaluate: test results, medication response, or physical findings reviewed by the provider
  • AAssess: explicit mention in the assessment or plan with acknowledgment of status
  • TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis

Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed F13.959 during that encounter — not just copy-forwarded from a problem list.

What This Code Means

F13.959 is the ICD-10-CM diagnosis code for sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified. A person is experiencing psychotic symptoms (delusions and/or hallucinations) caused by sedative, hypnotic, or anti-anxiety medication use, but the specific type is not specified. F13.959 sits in the ICD-10-CM chapter for mental, behavioral and neurodevelopmental disorders (f01-f99), within the section covering mental and behavioral disorders due to psychoactive substance use (f10-f19).

Under the CMS-HCC V28 risk adjustment model, F13.959 maps to Drug/Alcohol Psychosis (HCC 135) with a community, non-dual, aged base RAF weight of 0.000. Under the older V24 model, F13.959 mapped to the same category but with a base RAF weight of 0.434 — V28 recalibrated weights across the entire model. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.

Query provider to determine if delusions, hallucinations, or both are present to assign more specific codes (F13.950 or F13.951). Because F13.959 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.

HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for F13.959 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.

Coding Tips

  • Query provider to determine if delusions, hallucinations, or both are present to assign more specific codes (F13.950 or F13.951)
  • Document whether psychotic symptoms resolve with substance discontinuation to confirm substance-induced etiology

Clinical Significance

This code captures unspecified sedative use with psychotic disorder where neither the use pattern nor the specific psychotic symptom type is documented. Despite the dual unspecified nature, this still maps to the highest substance use HCC category due to the psychotic component. It represents a significant documentation improvement opportunity on both axes.

Documentation Requirements

  • Documentation of sedative, hypnotic, or anxiolytic use
  • Evidence of substance-induced psychotic symptoms
  • Clinical assessment confirming substance-induced rather than primary psychosis
  • Timeline of substance use and psychotic symptom onset
  • Note explaining why specific details could not be determined

Commonly Confused Codes

Code Hierarchy

Open F13.959 in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.